MDXH
MDXH
NASDAQ · Biotechnology

Mdxhealth

$0.84
-0.01 (-1.14%)
Financial Highlights (FY 2026)
Revenue
99.50M
Net Income
-30,918,872
Gross Margin
64.5%
Profit Margin
-31.1%
Rev Growth
+42.8%
D/E Ratio
4.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 64.5% 64.5% 34.0% 34.0%
Operating Margin -13.5% -12.1% 24.7% 24.4%
Profit Margin -31.1% -29.5% 22.7% 21.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 99.50M 69.69M 27.35M 20.96M
Gross Profit 64.23M 44.98M 9.30M 7.12M
Operating Income -13,432,980 -8,466,756 6.75M 5.11M
Net Income -30,918,872 -19,488,048 6.20M 4.50M
Gross Margin 64.5% 64.5% 34.0% 34.0%
Operating Margin -13.5% -12.1% 24.7% 24.4%
Profit Margin -31.1% -29.5% 22.7% 21.5%
Rev Growth +42.8% +42.8% -0.5% +20.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 18.15M 18.15M 71.52M 80.61M
Total Equity 4.54M 4.54M 72.48M 68.20M
D/E Ratio 4.00 4.00 0.99 1.18
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -6,940,501 -4,617,603 9.44M 6.87M
Free Cash Flow 4.10M 4.11M